FDA Approves First Cell Therapy for Solid Tumors, Marking a Significant Milestone In a groundbreaking development, the U.S. Food and...
Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
Using Microrobots Controlled by a Magnetic Field for the Treatment of Liver Cancer Liver cancer is a serious and potentially...
Potential for cancer treatment demonstrated by metal-free graphene quantum dots Graphene, a two-dimensional material made up of a single layer...
Gilead Sciences, a leading biopharmaceutical company, has recently announced its plans to expand its investment in Arcus Biosciences and its...
Providence Swedish Radiosurgery Center in Seattle Expands with Second Accuray CyberKnife® System, Enhancing Precision in Radiation Treatments Providence Swedish Radiosurgery...
Aulos Bioscience, a leading biotechnology company, has recently announced the administration of the first dose to a patient in the...
Understanding the Implications of Gilead’s Trodelvy Challenges and Elevation Oncology’s Unexpected Success In the world of oncology, the development and...
The Creation of a Living Biobank of Brain Metastasis Samples for Advancing Personalized Medicine Brain metastasis, the spread of cancer...
Strand Therapeutics, a leading biotechnology company specializing in developing innovative RNA-based therapies, has recently received approval from the Food and...
Gilead’s ADC Medicine Falls Short of Target in Highly Monitored Lung Cancer Study Gilead Sciences, a leading biopharmaceutical company, recently...
The Food and Drug Administration (FDA) has recently approved a groundbreaking drug called Balversa (erdafitinib) for the treatment of FGFR3+...
Novartis, a leading pharmaceutical company, has recently released comprehensive information on the initial results of their radiopharmaceutical drug, Lutathera, as...
Novocure, a global oncology company specializing in the development of innovative cancer therapies, has recently submitted a Premarket Approval (PMA)...
The Significance of Cell-Free DNA in Developing Advanced Cancer Treatments: Implications for the Biotech Industry Cancer continues to be one...
